Skip to content
Investing

Pulsar Helium: Investor Profile of the Minnesota Helium Explorer and Its Rare Gas Hub Plan

Pulsar Helium has found high-grade primary helium at Topaz in Minnesota and plans a helium and CO2 plant in Two Harbors. Its assets, latest numbers, cash, share count, risks and dates to watch.

Crew members work on a wellhead at Pulsar Helium's Topaz project in Minnesota, with red valve wheels in front and gas venting behind them.
Photo: Pulsar Helium

Pulsar Helium is an early-stage helium company with its main project in northern Minnesota, where it has drilled gas wells with unusually high helium content. It is now trying to turn that discovery into a business by building a processing plant, while it has no revenue. This profile sets out what it owns, its latest numbers and the main risks.

What Pulsar does and where

Pulsar's shares are quoted on London's AIM market and listed on the TSX Venture Exchange under PLSR, and trade over the counter in the US as PSRHF. It calls itself a primary helium company, meaning it targets helium that is not a by-product of oil or natural gas production.

The portfolio has three named projects: Topaz in Minnesota, the flagship; Falcon in Michigan, where exploration had not begun as of its 4 November release; and Tunu in Greenland. On 5 October Pulsar signed a contract for an airborne geophysical survey at Falcon.

Leadership changed on 30 October. Cliff Cain, previously president, became chief executive and joined the board. Thomas Abraham-James moved from chief executive to executive chairman, and co-founder Neil Herbert retired as executive chairman. David Young became chief financial officer and a director in September, and Canaccord Genuity was named sole broker.

Pulsar Helium: share price, chart and news

Key assets

Topaz. The project lies in Lake County, about 65 miles north of Duluth, inside the Duluth igneous complex. Pulsar holds it through exclusive leases over private mineral rights and in May 2026 bought surface land within the project for US$2.48 million. The company says it has drilled seven wells there, all of which encountered helium, including five appraisal core holes between October 2025 and March 2026.

Flow tests averaged 8.1% helium at Jetstream #1 and 5.6% at Jetstream #2, with gas flowing naturally to surface under pressure. Pulsar's project page notes that the industry generally treats concentrations above 0.3% as potentially economic. In January two US federal laboratories confirmed helium-3, a rare isotope with uses in quantum computing and fusion research, at 11.2 to 11.9 parts per billion in Jetstream #1 gas. On 14 October Pulsar signed an evaluation agreement with Lunar Helium-3 Mining to assess recovery of the isotope at Topaz.

Pulsar has not reported helium reserves at Topaz.

The Rare Gas Hub. On 1 October Pulsar accepted a binding proposal from Chart Energy & Chemicals, part of Baker Hughes, to supply equipment for a helium liquefaction plant of 861 litres an hour and a 300-tonne-a-day CO2 plant, at a total equipment price of US$85.5 million paid in stages. On 14 October the city of Two Harbors approved an agreement under which Pulsar could acquire industrial land, appraised at US$143,200, for US$1, with up to US$1 million of city money for a rail spur and a partial property-tax rebate for 15 years.

Two Harbors sits on Lake Superior with access to Canadian National's main rail line and a deep-water port. The agreement gives Pulsar 365 days of due diligence and lets either side walk away without penalty if Pulsar has not committed to the project by then. Power, gas and rail terms are still to be agreed.

Topaz itself has road access and three-phase grid power, with a railway about 5.5 miles to the south, according to the company's project page.

Latest numbers

Pulsar's financial year ends on 30 September. Its last published accounts cover the nine months to 30 June 2026.

Pulsar Helium in figures

  • US$24.6m unaudited cash at 12 October 2026
  • US$19.4m net loss for the nine months to 30 June 2026
  • 214.8m shares in issue after the November admission

The nine-month loss compares with US$8.5 million a year earlier and includes a non-cash loss of US$3.4 million on revaluing warrants. Exploration and evaluation spending at Topaz was US$8.0 million. During the period Pulsar raised US$9.9 million in a placement, US$5.3 million from warrant exercises and US$2.2 million from options.

After the period it closed a further placement of 25.4 million shares at 75 pence each, raising US$25.5 million before a US$1.2 million finder's fee. Share options granted in November carry an exercise price of C$1.295.

Main risks

Funding and dilution. The US$85.5 million covers equipment only, and the total installed cost has not been estimated. Pulsar prefers bank and public-sector loans, but none has been committed, and the company itself flags that it may need to issue equity. A US$8.55 million equipment payment falls due on 31 January 2027.

No revenue, no reserves. Pulsar produces nothing yet. Any estimate of how much helium Topaz holds carries large uncertainty and may change with more drilling and testing.

Permits and approvals. Minnesota passed helium-specific legislation in May 2026, and the state's natural resources department is still finalising permanent permitting rules. The plant needs environmental review, zoning and utility agreements, and the Chart proposal still needed TSX Venture Exchange approval as of 2 November.

Commercial risk. Pulsar has no gas processing customers or offtake contracts, and helium prices could change before any plant runs. On 23 October the US Department of Energy added helium to its critical materials list, which Pulsar has cited as support, but that does not guarantee prices or funding.

What to watchTiming
TSXV approval of the Chart proposalPending
Drilling of up to six more Topaz wellsSlated for the first quarter of 2027
Second Chart payment of US$8.55m31 January 2027
Annual results for the year to 30 September 2026Next scheduled financial report
Two Harbors due-diligence period endsOctober 2027
Binding financing and installed-cost estimateNo date given

What comes next

Pulsar has said it is funded for the next drilling step, which adds up to six wells to the two production-ready holes already drilled. The bigger test is whether it can line up debt for the plant before the January payment. Under the Two Harbors agreement, once Pulsar formally commits to the project it must reach commercial operation of the first phase within 36 months, subject to extensions. The company has not given a date for first commercial production.

Sources

Related stories

Business

Pulsar Helium Sets Out a Debt-Led Plan to Fund Its US$85.5m Minnesota Helium Plant

Pulsar Helium plans to fund its Minnesota helium and CO2 plant mainly with project debt and public-sector loans plus its own cash, after accepting a US$85.5m equipment proposal…

Investing

Serve Robotics Profile: The Sidewalk Robot Fleet, Its Numbers and the Risks for Investors

Serve Robotics runs more than 2,000 sidewalk delivery robots and now hospital robots too. Revenue is growing fast from a small base, but losses are large and it relies on $198m of…

Investing

Ivanhoe Electric: The Arizona Copper Developer Behind the Santa Cruz Project

Ivanhoe Electric is moving its Santa Cruz copper project in Arizona towards construction, with $215m of cash against a $1.43bn upfront cost. Its assets, numbers, risks and the…

Investing

Denison Mines Investor Profile: Wheeler River, the Phoenix Build and the Road to 2028

Denison Mines is building Phoenix, a high-grade in-situ uranium mine in Saskatchewan, with first output targeted for late 2028. Its assets, latest numbers, funding, risks and the…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…